Diligence memo · auto-generated · as of July 2, 2026
X1 Biotech Inc.
X1 Biotech Inc. looks under-valued against its niche peers and is at-risk on financing cadence.
Businessfiled
X1 Biotech Inc. operates in Biotech, based in NEEDHAM.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
X1 Biotech Inc. has raised $100K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $100K on 2023-11-07.
Most recent recorded round closed around 2023-11-07.
Valuation (modeled)modeled
Provath models X1 Biotech Inc. at approximately $691K (range $53K–$2.8M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.38× the median modeled value of Pre-Seed Biotech companies in 2022–2024 (5 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 2.7 yr ago; this sector typically re-raises about every 11 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
Comparablesmixed
Capital scale ranks ahead of 68% of Biotech peers (233 compared).
Modeled value ranks above 68% of those peers.
Closest niche peers: Antlia Bioscience, Inc., Innovation1 Biotech Inc., Bodhi Tree Biotechnology Inc, Biotech Social Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.